Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

THE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites.

Chang HH, Worby CJ, Yeka A, Nankabirwa J, Kamya MR, Staedke SG, Dorsey G, Murphy M, Neafsey DE, Jeffreys AE, Hubbart C, Rockett KA, Amato R, Kwiatkowski DP, Buckee CO, Greenhouse B.

PLoS Comput Biol. 2017 Jan 26;13(1):e1005348. doi: 10.1371/journal.pcbi.1005348. eCollection 2017 Jan 26.

2.

Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.

Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante AA, Plowe CV, Laufer MK, Takala-Harrison S.

J Infect Dis. 2015 Sep 1;212(5):694-701. doi: 10.1093/infdis/jiv078. Epub 2015 Feb 11.

3.

Maximum likelihood estimation of frequencies of known haplotypes from pooled sequence data.

Kessner D, Turner TL, Novembre J.

Mol Biol Evol. 2013 May;30(5):1145-58. doi: 10.1093/molbev/mst016. Epub 2013 Jan 30.

4.

Differentiating Plasmodium falciparum alleles by transforming Cartesian X,Y data to polar coordinates.

DaRe JT, Kouri DP, Zimmerman PA, Thomas PJ.

BMC Genet. 2010 Jun 29;11:57. doi: 10.1186/1471-2156-11-57.

6.

Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.

Kissel HD, Galipeau PC, Li X, Reid BJ.

Cancer Biomark. 2009;5(3):143-58. doi: 10.3233/CBM-2009-0618.

7.

A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking.

Daniels R, Volkman SK, Milner DA, Mahesh N, Neafsey DE, Park DJ, Rosen D, Angelino E, Sabeti PC, Wirth DF, Wiegand RC.

Malar J. 2008 Oct 29;7:223. doi: 10.1186/1475-2875-7-223.

8.
9.

A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes.

Dent AE, Yohn CT, Zimmerman PA, Vulule J, Kazura JW, Moormann AM.

Am J Trop Med Hyg. 2007 Aug;77(2):250-5.

10.
11.

Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.

Takala SL, Coulibaly D, Thera MA, Dicko A, Smith DL, Guindo AB, Kone AK, Traore K, Ouattara A, Djimde AA, Sehdev PS, Lyke KE, Diallo DA, Doumbo OK, Plowe CV.

PLoS Med. 2007 Mar;4(3):e93.

12.

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.

Thera MA, Doumbo OK, Coulibaly D, Diallo DA, Sagara I, Dicko A, Diemert DJ, Heppner DG Jr, Stewart VA, Angov E, Soisson L, Leach A, Tucker K, Lyke KE, Plowe CV; Mali FMP1 Working Group..

PLoS Clin Trials. 2006 Nov 24;1(7):e34.

13.

Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections.

Kwiek JJ, Alker AP, Wenink EC, Chaponda M, Kalilani LV, Meshnick SR.

Antimicrob Agents Chemother. 2007 Feb;51(2):521-7. Epub 2006 Nov 20.

14.

Plasmodium falciparum: a novel method for analyzing haplotypes in mixed infections.

Certain LK, Sibley CH.

Exp Parasitol. 2007 Mar;115(3):233-41. Epub 2006 Oct 17.

Supplemental Content

Support Center